-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Contineum Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2023 to Q4 2024.
- Contineum Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was 2.16 USD/shares, a 40.2% decline year-over-year.
- Contineum Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -2.18 USD/shares, a 260% decline year-over-year.
- Contineum Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -2.18 USD/shares, a 260% decline from 2023.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)